Carefully Designing De-escalation Trials in Breast Cancer

Over the past few years, several new, highly effective treatment strategies have improved survival outcomes in patients with early breast cancer. “We’ve been very fortunate” to see these advances, Sara M. Tolaney, MD, MPH, chief, Division of Breast Oncology, Dana-Farber Cancer Institute, Boston, told attendees at the ESMO Breast Cancer 2024 annual congress…

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button